Trial · NCT07417813
A Multicenter Observational Study of Lemborexant on Insomnia Patients With Psychiatric Disorders
NCT07417813, Recruiting, Shanghai Mental Health Center
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Multicenter Observational Study of Lemborexant on Insomnia Patients With Psychiatric Disorders. Trials, record NCT07417813. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07417813
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Multicenter Observational Study of Lemborexant on Insomnia Patients With Psychiatric Disorders
- NCT number
- NCT07417813
- Status
- Recruiting
- Enrollment
- 121 participants, estimated
- Lead sponsor
- Shanghai Mental Health Center
- Conditions
- Insomnia, Psychiatric Disorders
- Interventions
- Lemborexant tablets
- First posted
- 2026-02-18
- Last updated
- 2026-02-18
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Insomnia Severity Index (ISI) Score from Baseline | Measurement time points: Baseline, Week 4 of treatment, Week 8 of treatment | Change in Insomnia Severity Index (ISI) Score from Baseline: Evaluated by the ISI scale (7 items, total score 0-28 points). |
| Secondary | ISI Treatment Response Rate | Measurement time points: Week 4 and Week 8 of treatment | Proportion of patients with an ISI score decrease of ≥7 points from baseline. |
| Secondary | ISI Remission Rate | Measurement time points: Week 4 and Week 8 of treatment | Proportion of patients with an ISI score \<8 points. |
| Secondary | Change in Sleep Satisfaction VAS Score | Measurement time points: Baseline, Week 4 and Week 8 of treatment | Including 3 dimensions (sleep onset efficiency, sleep maintenance, impact on daytime function) with 1-10 points for each dimension. |
| Secondary | Change in Epworth Sleepiness Scale (ESS) Score | Measurement time points: Baseline, Week 4 and Week 8 of treatment | Change in Epworth Sleepiness Scale (ESS) Score: Total score 0-24 points. |
| Secondary | Lemborexant Treatment Retention Rate | Week 4 and Week 8 of treatment | Lemborexant Treatment Retention Rate: Proportion of patients still using lemborexant at Week 4 and Week 8 of treatment; |
| Secondary | BZRAs Discontinuation Rate | Measurement time points: Week 4 and Week 8 of treatment | Discontinuation rate of patients using BZRAs at baseline |
| Secondary | BZRAs Dose Change | Measurement time points: Week 4 and Week 8 of treatment | Change in diazepam-equivalent dose from baseline |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07417813
GET https://conductscience.org/api/trials/v1/NCT07417813/registered